Curcumin-like diarylpentanoid analogues as melanogenesis inhibitors

J Nat Med. 2012 Jan;66(1):166-76. doi: 10.1007/s11418-011-0568-0. Epub 2011 Aug 10.

Abstract

Anti-melanogenesis screening of 47 synthesized curcumin-like diarylpentanoid analogues was performed to show that some had a potent inhibitory effect on the melanogenesis in B16 melanoma cells. Their actions were considered to be mostly due to tyrosinase inhibition, tyrosinase expression inhibition, and melanin pigment degradation. The structure-activity relationships of those curcumin-like diarylpentanoid analogues which inhibited the melanogenesis and tyrosinase activity were also discussed. Of those compounds assayed, (2E,6E)-2,6-bis(2,5-dimethoxybenzylidene)cyclohexanone showed the most potent anti-melanogenesis effect, the mechanism of which is considered to be the degradation of the melanin pigment in B16 melanoma cells, affecting neither the tyrosinase activity nor tyrosinase expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Curcumin / analogs & derivatives
  • Curcumin / chemical synthesis
  • Curcumin / pharmacology*
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Melanins / metabolism*
  • Melanocytes / drug effects*
  • Melanocytes / enzymology
  • Melanocytes / pathology
  • Melanoma, Experimental / enzymology*
  • Melanoma, Experimental / pathology
  • Mice
  • Molecular Structure
  • Monophenol Monooxygenase / antagonists & inhibitors
  • Monophenol Monooxygenase / metabolism
  • Structure-Activity Relationship

Substances

  • Enzyme Inhibitors
  • Melanins
  • Monophenol Monooxygenase
  • Curcumin